FLT3 and acute myeloid leukemia: Similar findings were observed in the high risk AML subset with pre HSCT positive AML: In MVA, adverse and intermediate/FLT3-ITD3 risk patients were more likely to experience disease relapse compared with favorable risk patients [19].